Literature DB >> 17988998

Can stem blood cell transplantation be an adjuvant treatment for primary cardiac lymphoma?

Reinaldo B Bestetti, Carlos E Miguel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17988998     DOI: 10.1532/IJH97.07124

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  6 in total

1.  Primary lymphoma of the right atrium with fatal neoplastic pulmonary embolism.

Authors:  R B Bestetti; F A Soares; E G Soares; J S Oliveira
Journal:  Am Heart J       Date:  1992-10       Impact factor: 4.749

Review 2.  Primary cardiac lymphoma and complete atrio-ventricular block: case report and review of the literature.

Authors:  Virginie Montiel; Nicolas Maziers; Thierry Dereme
Journal:  Acta Cardiol       Date:  2007-02       Impact factor: 1.718

3.  Successful treatment of primary cardiac B-cell lymphoma: depiction at multislice computed tomography and magnetic resonance imaging.

Authors:  Yuichi Sato; Naoya Matsumoto; Noriko Kinukawa; Shinro Matsuo; Sei Komatsu; Taeko Kunimasa; Shunichi Yoda; Shigemasa Tani; Tadateru Takayama; Yuji Kasamaki; Satoshi Kunimoto; Satoru Furuhashi; Motoichiro Takahashi; Satoshi Saito
Journal:  Int J Cardiol       Date:  2006-10-16       Impact factor: 4.164

4.  Primary cardiac plasmablastic (diffuse large B-cell) lymphoma mimicking left ventricular aneurysm with mural thrombus.

Authors:  Dylan V Miller; Farouk Mookadam; Martina Mookadam; William D Edwards; William R Macon
Journal:  Cardiovasc Pathol       Date:  2007 Mar-Apr       Impact factor: 2.185

Review 5.  Clinical perspectives of primary cardiac lymphoma.

Authors:  Ramesh M Gowda; Ijaz A Khan
Journal:  Angiology       Date:  2003 Sep-Oct       Impact factor: 3.619

6.  Successful treatment of primary cardiac lymphoma by rituximab-CHOP and high-dose chemotherapy with autologous peripheral blood stem cell transplantation.

Authors:  Atsushi Nonami; Katsuto Takenaka; Kenjiro Kamezaki; Toshihiro Miyamoto; Naoki Harada; Koji Nagafuji; Takanori Teshima; Mine Harada
Journal:  Int J Hematol       Date:  2007-04       Impact factor: 2.490

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.